Citations 1
Carfilzomib 56 mg/m 2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment
Terpos, Evangelos , Spencer, Andrew , Goldschmidt, Hartmut , Dirnberger, Franziska, DeCosta, Lucy, Yusuf, Akeem , Kumar, Shaji , Terpos, Evangelos , Goldschmidt, Hartmut , Kumar, Shaji K , Weisel, Katja C , Nooka, Ajay K.
Leukemia & Lymphoma | March 15, 2022 | Volume: 63 | Issue: 8 | Pages: 1887-1896
